Table I.
Baseline characteristics of study groups
| Parameter | Group I Patients without metabolic syndrome (33 patients) | Group II Patients with metabolic syndrome (36 patients) | P-value |
|---|---|---|---|
| Age [years] | 57 ±8 | 60 ±12 | 0.14 |
| Women (n) | 5 | 15 | |
| Body mass [kg] | 77 ±11 | 91 ±13 | < 0.0001 |
| BMI [kg/m2] | 26 ±2 | 33 ±4 | < 0.0001 |
| WHR | 0.80 ±0.1 | 1.21 ±0.1 | < 0.0001 |
| Hypertension (n) | 35 | 32 | 0.95 |
| Smoking (n) | 15 | 6 | 0.038 |
| Diabetes (n) | 3 | 21 | < 0.0001 |
| Cholesterol [mg/dl] | 203 ±38 | 204 ±34.5 | 0.93 |
| Triglycerides [mg/dl] | 125 ±57 | 172 ±152 | 0.21 |
| HDL [mg/dl] | 51 ±13 | 44 ±11 | 0.017 |
| LDL [mg/dl] | 127 ±31 | 129 ±30 | 0.86 |
| HbA1c (%) | 5.7 ±0.6 | 6.6 ±0.6 | < 0.001 |
| CK MB (mass) [µg/l] | 144 ±148 | 121 ±120 | 0.51 |
| Troponin I [µg/l] | 4.2 ±3.6 | 4.4 ±4.9 | 0.9 |
BMI – body mass index, WHR – waist-to-hip ratio, HDL – high-density lipoprotein, LDL – low-density lipoprotein, HbA1c – glycated hemoglobin, CK-MB – creatine kinase-myocardial band, n – number of patients.